Trial intelligence / Profile preview

N-acetylcysteine in chronic hemodialysis patients

IRCT201201108679N1Phase 2Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of acetylcysteine in end-stage kidney disease (ESKD) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Jan 2013; status: completed.

02

Drugs

acetylcysteine
03

Conditions

end-stage kidney disease (ESKD)

Beyond the preview

Go deeper on IRCT201201108679N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201201108679N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call